Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.

Background: The aim of this study was to investigate the prognostic value of the PAM50 intrinsic subtypes and risk of recurrence (ROR) score in patients with early breast cancer and long-term follow-up. A special focus was placed on hormone receptor-positive/human epidermal growth factor receptor 2-...

Descripción completa

Detalles Bibliográficos
Publicado en:Breast Cancer Research Vol. 19; pp. 1 - 13
Autores principales: Ohnstad, Hege O., Borgen, Elin, Falk, Ragnhild S., Lien, Tonje G., Aaserud, Marit, Sveli, My Anh T., Kyte, Jon A., Kristensen, Vessela N., Geitvik, Gry A., Schlichting, Ellen, Wist, Erik A., Sørlie, Therese, Russnes, Hege G., Naume, Bjørn
Formato: Journal Article
Publicado: BioMed Central 11/14/2017
Acceso en línea:Ver este registro en EBSCOhost